Skip to main content
HCPCS J2543 · Level II · Part B drug

J2543: piperacillin sodium/tazobactam sodium (Zosyn), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J2543

Billing unit
1.125 GM
Piperacillin/tazobactam
ASP payment limit
$1.183
October 2026; -2.9% vs July 2026
Practitioner MUE
16
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
0
none list this code

TL;DR

HCPCS J2543 is the Level II code for Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams), billed per 1.125 GM. The Medicare Part B ASP payment limit for October 2026 is $1.183 per billing unit, down 2.9% from July 2026. The practitioner MUE allows up to 16 units per date of service (MAI 3), so a full 16-unit day is $18.93 at the current limit. Under OPPS it carries status indicator N. J2543 is billed in units of 1.125 GM; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. The ASP crosswalk maps 75 NDCs to it, sold as Piperacillin Sodium-Tazobactam Sodium, Zosyn, Piperacillin And Tazobactam by B. Braun Medical Inc., Baxter Healthcare Corporation, Pfizer Inc. No current Billing and Coding Article lists J2543, so coverage follows the FDA label, compendia and any applicable NCD.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J2543 at $1.183 per 1.125 GM for October 2026, derived from manufacturer average sales price plus 6%, compared with $1.218 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J2543
QuarterPayment limitPerCoinsurance
October 2026$1.1831.125 GM20%
July 2026$1.2181.125 GM—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 75 NDCs from 17 labelers to J2543. Report the NDC in the claim's drug segment and bill the number of J2543 units that equals the quantity administered divided by 1.125 GM; the last column gives units per full package.

NDCs that crosswalk to J2543
NDCDrug nameLabelerPackage sizeBilling units / package
00264-3446-11Piperacillin Sodium-Tazobactam SodiumB. Braun Medical Inc.1 × 2448
00264-3448-11Piperacillin Sodium-Tazobactam SodiumB. Braun Medical Inc.1 × 2472
00264-3450-22Piperacillin Sodium-Tazobactam SodiumB. Braun Medical Inc.1 × 2496
00338-9632-24ZosynBaxter Healthcare Corporation1 × 2448
00338-9636-24ZosynBaxter Healthcare Corporation1 × 2472
00338-9638-12ZosynBaxter Healthcare Corporation1 × 1248
00409-2999-14Piperacillin Sodium-Tazobactam SodiumPfizer Inc1 × 112
00409-3374-02Piperacillin Sodium-Tazobactam SodiumPfizer Inc1 × 1020
00409-3378-13Piperacillin Sodium-Tazobactam SodiumPfizer Inc1 × 1030
00409-3379-04Piperacillin Sodium-Tazobactam SodiumPfizer Inc1 × 1040
00409-3383-02Piperacillin Sodium-Tazobactam SodiumPfizer Inc1 × 1020
00409-3383-10Piperacillin Sodium-Tazobactam SodiumPfizer Inc1 × 1020
00409-3385-13Piperacillin Sodium-Tazobactam SodiumPfizer Inc1 × 1030
00409-3385-15Piperacillin Sodium-Tazobactam SodiumPfizer Inc1 × 1030
00409-3390-04Piperacillin Sodium-Tazobactam SodiumPfizer Inc1 × 1040
00409-3390-10Piperacillin And TazobactamPfizer Inc1 × 1040
00781-3110-95Piperacillin Sodium-Tazobactam SodiumSandoz Inc.1 × 1020
00781-3113-95Piperacillin Sodium-Tazobactam SodiumSandoz Inc.1 × 1030
00781-3114-95Piperacillin Sodium-Tazobactam SodiumSandoz Inc.1 × 1040
00781-3180-94Piperacillin Sodium-Tazobactam SodiumSandoz Inc.1 × 136
00781-9210-95Piperacillin Sodium-Tazobactam SodiumSandoz Inc.1 × 1020
00781-9213-95Piperacillin Sodium-Tazobactam SodiumSandoz Inc.1 × 1030
00781-9214-95Piperacillin Sodium-Tazobactam SodiumSandoz Inc.1 × 1040
25021-0164-30Piperacillin Sodium-Tazobactam SodiumSagent Pharmaceuticals1 × 1020
25021-0165-30Piperacillin Sodium-Tazobactam SodiumSagent Pharmaceuticals1 × 1030
25021-0166-48Piperacillin Sodium-Tazobactam SodiumSagent Pharmaceuticals1 × 1040
25021-0181-99Piperacillin Sodium-Tazobactam SodiumSagent Pharmaceuticals1 × 136
44567-0801-10Piperacillin Sodium-Tazobactam SodiumWG Critical Care, LLC1 × 1020
44567-0802-10Piperacillin Sodium-Tazobactam SodiumWG Critical Care, LLC1 × 1030
44567-0803-10Piperacillin Sodium-Tazobactam SodiumWG Critical Care, LLC1 × 1040
44567-0804-01Piperacillin Sodium-Tazobactam SodiumWG Critical Care, LLC1 × 136
55150-0119-30Piperacillin Sodium-Tazobactam SodiumEugia US LLC1 × 1020
55150-0120-30Piperacillin Sodium-Tazobactam SodiumEugia US LLC1 × 1030
55150-0121-50Piperacillin Sodium-Tazobactam SodiumEugia US LLC1 × 1040
60505-6156-04Piperacillin Sodium-Tazobactam SodiumApotex Corp1 × 1020
60505-6157-04Piperacillin Sodium-Tazobactam SodiumApotex Corp1 × 1030
60505-6159-04Piperacillin Sodium-Tazobactam SodiumApotex Corp1 × 1040
60505-6262-00Piperacillin Sodium-Tazobactam SodiumApotex Corp1 × 136
61990-0110-02Piperacillin Sodium-Tazobactam SodiumApollo Pharmaceuticals Inc.1 × 1020
61990-0120-02Piperacillin Sodium-Tazobactam SodiumApollo Pharmaceuticals Inc.1 × 1030
61990-0130-02Piperacillin Sodium-Tazobactam SodiumApollo Pharmaceuticals Inc.1 × 1040
61990-0150-01Piperacillin Sodium-Tazobactam SodiumApollo Pharmaceuticals Inc.1 × 136
63323-0981-21Piperacillin Sodium-Tazobactam SodiumFreseniUS Kabi USA, LLC1 × 1020
63323-0981-53Piperacillin Sodium-Tazobactam SodiumFreseniUS Kabi USA, LLC1 × 1020
63323-0983-21Piperacillin Sodium-Tazobactam SodiumFreseniUS Kabi USA, LLC1 × 1030
63323-0983-53Piperacillin Sodium-Tazobactam SodiumFreseniUS Kabi USA, LLC1 × 1030
65219-0256-00Piperacillin Sodium-Tazobactam SodiumFreseniUS Kabi USA, LLC1 × 136
65219-0256-24Piperacillin Sodium-Tazobactam SodiumFreseniUS Kabi USA, LLC1 × 136
65219-0256-28Piperacillin Sodium-Tazobactam SodiumFreseniUS Kabi USA, LLC1 × 136
65219-0259-45Piperacillin Sodium-Tazobactam SodiumFreseniUS Kabi USA, LLC1 × 1040
65219-0259-55Piperacillin Sodium-Tazobactam SodiumFreseniUS Kabi USA, LLC1 × 1040
65219-0434-20Piperacillin Sodium-Tazobactam SodiumFreseniUS Kabi USA, LLC1 × 1020
65219-0436-20Piperacillin Sodium-Tazobactam SodiumFreseniUS Kabi USA, LLC1 × 1030
66794-0216-41Piperacillin Sodium-Tazobactam SodiumPiramal Critical Care Inc1 × 1020
66794-0217-41Piperacillin Sodium-Tazobactam SodiumPiramal Critical Care Inc1 × 1030
66794-0218-41Piperacillin Sodium-Tazobactam SodiumPiramal Critical Care Inc1 × 1040
68001-0506-30Piperacillin Sodium-Tazobactam SodiumBluePoint Laboratories1 × 1020
68001-0507-82Piperacillin Sodium-Tazobactam SodiumBluePoint Laboratories1 × 1030
68001-0508-31Piperacillin Sodium-Tazobactam SodiumBluePoint Laboratories1 × 1040
70860-0120-20Piperacillin Sodium-Tazobactam SodiumAthenex Pharmaceutical Division, LLC1 × 1020
Showing 60 of 75 NDCs.

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J2543. For practitioners the limit is 16 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J2543 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services163 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital203 Date of Service Edit: ClinicalPrescribing Information
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J2543 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J2543 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J2543 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J2543 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

No current Billing and Coding Article lists J2543 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J2543 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J2543 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J2543 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J2543

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J2543

What does HCPCS code J2543 describe?

J2543 is defined by CMS as "Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)". Each billing unit represents 1.125 GM, so the units reported on the claim must equal the dose administered divided by that unit.

Is J2543 a CPT code?

No. J2543 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as piperacillin sodium/tazobactam sodium (Zosyn); CPT codes are five-character codes maintained by the AMA. On a Part B claim J2543 reports the drug itself in 1.125 gm units, and the administration is billed on its own line.

What is the Medicare reimbursement for J2543 in October 2026?

The ASP-based payment limit is $1.183 per 1.125 GM, with 20% beneficiary coinsurance. The July 2026 limit was $1.218. Commercial payers use their own fee schedules.

How many units of J2543 can be billed per day?

The practitioner Medically Unlikely Edit is 16 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). The facility outpatient MUE is 20. MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J2543?

The October 2026 ASP crosswalk lists 75 NDCs from 17 labelers: Piperacillin Sodium-Tazobactam Sodium (B. Braun Medical Inc.); Zosyn (Baxter Healthcare Corporation); Piperacillin Sodium-Tazobactam Sodium (Pfizer Inc); Piperacillin And Tazobactam (Pfizer Inc). For example NDC 00264-3446-11 (package size 1) equals 48 billing units of J2543.

Does J2543 have NCCI bundling edits?

No active practitioner PTP pairs list J2543 as a column-1 or column-2 code in the v323r0 release.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.